INORIAL 2.5 mg/ml, oral solution bottle, 120 ml
Active ingredients: Bilastine
Commercialized according to BDPMDispensing in France: Prescription only
Oral solutionbottle, 120 mlorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- INORIAL 2,5 mg/ml, solution buvable
- Pharmaceutical form
- solution buvable
- Route of administration
- orale
- Presentation description
- 1 bouteille(s) en verre jaune(brun) de 120 ml avec un système de fermeture inviolable ou avec fermeture de sécurité enfant avec gobelet(s) doseur(s) polypropylène
- Marketing authorisation holder
- MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 30 Aug 2025
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67280591CIP73014162CIP133400930141625Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| BILASTINEsolution | 2,5 mg · 1 ml de solution | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.